Skip to main content
. Author manuscript; available in PMC: 2019 Jan 11.
Published in final edited form as: J Gastrointest Surg. 2018 Sep 21;23(1):112–121. doi: 10.1007/s11605-018-3966-8

Table 2.

Clinicopathological characteristics of 96 patients with resected BRPC

Variables N (%)
Time from diagnosis to surgery (months), median (IQR) 6.2 (4.3–7.7)
Type of pancreatectomy, n (%)
 Pancreaticoduodenectomy 79 (82.3)
 Distal pancreatectomy 14 (14.6)
 Total pancreatectomy 3 (3.1)
Need for vascular resection, n (%) 47 (48.9)
Tumor size (cm), median (IQR) 2.8 (1.8–3.9)
Grade of tumor differentiation, n (%)
 Well differentiated 1 (1.2)
 Moderately differentiated 54 (65.9)
 Poorly differentiated/undifferentiated 27 (32.9)
Perineural invasion (present), n (%) 68 (71.6)
Lymphovascular invasion (present), n (%) 47 (48.9)
Nodal disease (present), n (%) 41 (42.7)
Margin status (negative), n (%) 74 (77.1)
Treatment effect
 Complete, n (%) 14 (16.7)
 Extensive, n (%) 21 (25.0)
 Moderate, n (%) 24 (28.6)
 Poor, n (%) 25 (29.7)
Adjuvant therapy (performed), n (%) 58 (60.4)
Recurrence of disease at last follow-up (present), n (%) 58 (60.4)
Type of recurrence, n (%)
 Local only 28 (48.3)
 Liver only 8 (13.8)
 Distant other than the liver 8 (13.8)
 Multiple sites 14 (24.1)